Antibiotic prescribing in general practice in England fell significantly during the first 12 months of the COVID-19 pandemic compared with the previous year, according to data released last week by Antibiotic Research UK (ANTRUK).
Among children with community-acquired pneumonia (CAP) who were discharged from the hospital within 48 hours but required further outpatient treatment, a lower dose of oral amoxicillin was non-inferior to a higher dose, and a 3-day duration was non-inferior to 7 days, according to the results of a randomized clinical trial published today in JAMA.
A study of preterm newborns in Canada found high rates of antimicrobial use in the first 7 days after birth, researchers reported last week in Infection Control & Hospital Epidemiology.
Antibiotic-resistant blood infection in pediatric pneumonia patients was tied to a 17-fold mortality risk.
Nearly 40% of outpatient antibiotic prescriptions in an integrated healthcare system in Denver were longer than necessary, researchers reported yesterday in Open Forum Infectious Diseases.
Antibiotic prescribing for young children in Israel sharply declined following implementation of pneumococcal conjugate vaccine (PCV), Israeli researchers reported today in Clinical Infectious Diseases.
A crowdsourcing appeal for creative solutions for safely reopening the University of North Carolina at Chapel Hill amid the COVID-19 pandemic in fall 2020 netted 82 submissions from 110 students, faculty, and staff, according to a qualitative study today in JAMA Network Open.
The results of a phase 2b clinical trial indicate 77% efficacy over 12 months of follow-up for a vaccine that targets malaria caused by Plasmodium falciparum, according to a preprint study published this week in The Lancet.
"We should work toward improving care for our patients with right-sized antibiotic courses."
CARB-X announced today that it is awarding more than $10 million to GSK to develop vaccines to prevent serious infections caused by common bacterial pathogens that pose a significant health threat in the developing world.
